HLOSF 株価推移チャート
HLOSF 株価予測
Healios K.K.
戻る
Healios K.K. (HLOSF) 株価予測
主要データ
前終値
$1.8
始値
$1.8
当日レンジ
$1.8 - $1.8
52週レンジ
$1.8 - $4.45
取引高
100
平均取引高
20
配当利回り
--
1株当たり利益(TTM)
-0.16
時価総額
$243.0M
HEALIOS K Kとは何ですか？
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 75 full-time employees. The company went IPO on 2015-06-16. The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.
